■ 영문 제목 : Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2023-2027
|
 | ■ 상품코드 : IRTNTR41149-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2023년 1월 ■ 페이지수 : 178
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 북미, 유럽, 아시아, 기타 지역
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
Single User (1명 열람용) | USD2,500 ⇒환산₩3,375,000 | 견적의뢰/주문/질문 |
Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산₩5,400,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
Technavio사(테크나비오)의 본 조사 보고서는 세계의 효소 면역 측정 (ELISA) 검사 시장 규모가 2022년부터 2027년 사이에 564.97백만 달러에 달하며, 예측기간 동안 연평균 13.6% 성장할 것으로 전망하고 있습니다. 또한 본 조사 자료는 세계의 효소 면역 측정 (ELISA) 검사 시장에 대해 조사하여, 개요, 시장 현황, 시장 규모 및 예측, 과거 시장 규모, 파이브 포스 분석, 용도별 (백신 개발, 면역, 진단, 약물 모니터링 및 제약, 기타) 분석, 최종 용도별 (병원 및 진단 센터, 연구소, 기타) 분석, 고객 현황, 지역별 (북미, 유럽, 아시아, 기타 지역, 미국, 중국, 영국), 독일, 일본) 분석, 성장 요인/과제/동향, 기업 현황, 기업 분석 등의 내용을 게재하고 있습니다. 또한 본 조사 자료는 Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Amgen Inc., Avantor Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Cardinal Health Inc., Crux Biolabs Pty Ltd., Danaher Corp., Eppendorf SE, Illumina Inc., Lonza Group Ltd., Merck KGaA, Novo Nordisk AS, Perkin Elmer Inc 등의 기업 정보가 포함되어 있습니다.
・개요
・시장 현황
・시장 규모 및 예측
・과거 시장 규모
・파이브 포스 분석
・세계의 효소 면역 측정 (ELISA) 검사 시장 규모 : 용도별
- 백신 개발에 사용되는 ELISA의 시장 규모
- 면역에 사용되는 ELISA의 시장 규모
- 진단에 사용되는 ELISA의 시장 규모
- 약물 모니터링 및 제약에 사용되는 ELISA의 시장 규모
- 기타 용도에 사용되는 ELISA의 시장 규모
・세계의 효소 면역 측정 (ELISA) 검사 시장 규모 : 최종 용도별
- 병원 및 진단 센터에서 사용되는 ELISA의 시장 규모
- 연구소에서 사용되는 ELISA의 시장 규모
- 기타 최종 용도에서 사용되는 ELISA의 시장 규모
・고객 현황
・세계의 효소 면역 측정 (ELISA) 검사 시장 규모 : 지역별
- 북미의 효소 면역 측정 (ELISA) 검사 시장 규모
- 유럽의 효소 면역 측정 (ELISA) 검사 시장 규모
- 아시아의 효소 면역 측정 (ELISA) 검사 시장 규모
- 기타 지역의 효소 면역 측정 (ELISA) 검사 시장 규모
- 미국의 효소 면역 측정 (ELISA) 검사 시장 규모
- 중국의 효소 면역 측정 (ELISA) 검사 시장 규모
- 영국의 효소 면역 측정 (ELISA) 검사 시장 규모
- 독일의 효소 면역 측정 (ELISA) 검사 시장 규모
- 일본의 효소 면역 측정 (ELISA) 검사 시장 규모
・성장 요인/과제/동향
・기업 현황
・기업 분석
Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
■ 보고서 개요Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2023-2027
Technavio has been monitoring the enzyme-linked immunosorbent assay (Elisa) testing market and is forecast to grow by $564.97 mn during 2022-2027, accelerating at a CAGR of 13.6% during the forecast period. Our report on the enzyme-linked immunosorbent assay (Elisa) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing need for frequent diagnostic testing among aging population, rise in toxicology testing in food industry, and the increase in chronic diseases.
Technavio’s enzyme-linked immunosorbent assay (Elisa) testing market is segmented as below:
By Application
• Vaccine development
• Immunology
• Diagnostics
• Drug monitoring and pharmaceutical industry
• Others
By End-user
• Hospitals and diagnostic centers
• Research laboratories
• Others
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the growing importance of promotional activities as one of the prime reasons driving the enzyme-linked immunosorbent assay (Elisa) testing market growth during the next few years. Also, increasing cases of cancer and the emergence of new disease targets will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the enzyme-linked immunosorbent assay (Elisa) testing market covers the following areas:
• Enzyme-linked immunosorbent assay (Elisa) testing market sizing
• Enzyme-linked immunosorbent assay (Elisa) testing market forecast
• Enzyme-linked immunosorbent assay (Elisa) testing market industry analysis
Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading enzyme-linked immunosorbent assay (Elisa) testing market vendors that include Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Amgen Inc., Avantor Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Cardinal Health Inc., Crux Biolabs Pty Ltd., Danaher Corp., Eppendorf SE, Illumina Inc., Lonza Group Ltd., Merck KGaA, Novo Nordisk AS, Perkin Elmer Inc, QIAGEN NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. Also, the enzyme-linked immunosorbent assay (Elisa) testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary.
Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global enzyme-linked immunosorbent assay (Elisa) testing market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global enzyme-linked immunosorbent assay (Elisa) testing market 2017 – 2021 ($ million)
o 4.2 Application Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.3 End User Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End User Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application – Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Vaccine development – Market size and forecast 2022-2027
o Exhibit 34: Chart on Vaccine development – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Vaccine development – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Vaccine development – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Vaccine development – Year-over-year growth 2022-2027 (%)
o 6.4 Immunology – Market size and forecast 2022-2027
o Exhibit 38: Chart on Immunology – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Immunology – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Immunology – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Immunology – Year-over-year growth 2022-2027 (%)
o 6.5 Diagnostics – Market size and forecast 2022-2027
o Exhibit 42: Chart on Diagnostics – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Diagnostics – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Diagnostics – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Diagnostics – Year-over-year growth 2022-2027 (%)
o 6.6 Drug monitoring and pharmaceutical industry – Market size and forecast 2022-2027
o Exhibit 46: Chart on Drug monitoring and pharmaceutical industry – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Drug monitoring and pharmaceutical industry – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Drug monitoring and pharmaceutical industry – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Drug monitoring and pharmaceutical industry – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Application
o Exhibit 54: Market opportunity by Application ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 55: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 56: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 57: Chart on Comparison by End-user
o Exhibit 58: Data Table on Comparison by End-user
o 7.3 Hospitals and diagnostic centers – Market size and forecast 2022-2027
o Exhibit 59: Chart on Hospitals and diagnostic centers – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Hospitals and diagnostic centers – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Hospitals and diagnostic centers – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Hospitals and diagnostic centers – Year-over-year growth 2022-2027 (%)
o 7.4 Research laboratories – Market size and forecast 2022-2027
o Exhibit 63: Chart on Research laboratories – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Research laboratories – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Research laboratories – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Research laboratories – Year-over-year growth 2022-2027 (%)
o 7.5 Others – Market size and forecast 2022-2027
o Exhibit 67: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 71: Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 75: Chart on Geographic comparison
o Exhibit 76: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 77: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 81: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 85: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 89: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 93: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 97: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 101: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 Germany – Market size and forecast 2022-2027
o Exhibit 105: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 109: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 110: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 111: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 112: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 113: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 114: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 116: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 117: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 118: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 119: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 120: Abbott Laboratories – Overview
o Exhibit 121: Abbott Laboratories – Business segments
o Exhibit 122: Abbott Laboratories – Key news
o Exhibit 123: Abbott Laboratories – Key offerings
o Exhibit 124: Abbott Laboratories – Segment focus
o 12.4 Abcam plc
o Exhibit 125: Abcam plc – Overview
o Exhibit 126: Abcam plc – Product / Service
o Exhibit 127: Abcam plc – Key news
o Exhibit 128: Abcam plc – Key offerings
o 12.5 Agilent Technologies Inc.
o Exhibit 129: Agilent Technologies Inc. – Overview
o Exhibit 130: Agilent Technologies Inc. – Business segments
o Exhibit 131: Agilent Technologies Inc. – Key news
o Exhibit 132: Agilent Technologies Inc. – Key offerings
o Exhibit 133: Agilent Technologies Inc. – Segment focus
o 12.6 Avantor Inc.
o Exhibit 134: Avantor Inc. – Overview
o Exhibit 135: Avantor Inc. – Business segments
o Exhibit 136: Avantor Inc. – Key offerings
o Exhibit 137: Avantor Inc. – Segment focus
o 12.7 Becton Dickinson and Co.
o Exhibit 138: Becton Dickinson and Co. – Overview
o Exhibit 139: Becton Dickinson and Co. – Business segments
o Exhibit 140: Becton Dickinson and Co. – Key news
o Exhibit 141: Becton Dickinson and Co. – Key offerings
o Exhibit 142: Becton Dickinson and Co. – Segment focus
o 12.8 Bio Rad Laboratories Inc.
o Exhibit 143: Bio Rad Laboratories Inc. – Overview
o Exhibit 144: Bio Rad Laboratories Inc. – Business segments
o Exhibit 145: Bio Rad Laboratories Inc. – Key news
o Exhibit 146: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 147: Bio Rad Laboratories Inc. – Segment focus
o 12.9 bioMerieux SA
o Exhibit 148: bioMerieux SA – Overview
o Exhibit 149: bioMerieux SA – Product / Service
o Exhibit 150: bioMerieux SA – Key offerings
o 12.10 Danaher Corp.
o Exhibit 151: Danaher Corp. – Overview
o Exhibit 152: Danaher Corp. – Business segments
o Exhibit 153: Danaher Corp. – Key news
o Exhibit 154: Danaher Corp. – Key offerings
o Exhibit 155: Danaher Corp. – Segment focus
o 12.11 Eppendorf SE
o Exhibit 156: Eppendorf SE – Overview
o Exhibit 157: Eppendorf SE – Product / Service
o Exhibit 158: Eppendorf SE – Key news
o Exhibit 159: Eppendorf SE – Key offerings
o 12.12 Merck KGaA
o Exhibit 160: Merck KGaA – Overview
o Exhibit 161: Merck KGaA – Business segments
o Exhibit 162: Merck KGaA – Key news
o Exhibit 163: Merck KGaA – Key offerings
o Exhibit 164: Merck KGaA – Segment focus
o 12.13 Novo Nordisk AS
o Exhibit 165: Novo Nordisk AS – Overview
o Exhibit 166: Novo Nordisk AS – Business segments
o Exhibit 167: Novo Nordisk AS – Key offerings
o Exhibit 168: Novo Nordisk AS – Segment focus
o 12.14 Perkin Elmer Inc
o Exhibit 169: Perkin Elmer Inc – Overview
o Exhibit 170: Perkin Elmer Inc – Business segments
o Exhibit 171: Perkin Elmer Inc – Key news
o Exhibit 172: Perkin Elmer Inc – Key offerings
o Exhibit 173: Perkin Elmer Inc – Segment focus
o 12.15 QIAGEN NV
o Exhibit 174: QIAGEN NV – Overview
o Exhibit 175: QIAGEN NV – Product / Service
o Exhibit 176: QIAGEN NV – Key news
o Exhibit 177: QIAGEN NV – Key offerings
o 12.16 Siemens Healthineers AG
o Exhibit 178: Siemens Healthineers AG – Overview
o Exhibit 179: Siemens Healthineers AG – Business segments
o Exhibit 180: Siemens Healthineers AG – Key news
o Exhibit 181: Siemens Healthineers AG – Key offerings
o Exhibit 182: Siemens Healthineers AG – Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 183: Thermo Fisher Scientific Inc. – Overview
o Exhibit 184: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 185: Thermo Fisher Scientific Inc. – Key news
o Exhibit 186: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 187: Thermo Fisher Scientific Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 188: Inclusions checklist
o Exhibit 189: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 190: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 191: Research methodology
o Exhibit 192: Validation techniques employed for market sizing
o Exhibit 193: Information sources
o 13.5 List of abbreviations
o Exhibit 194: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global enzyme-linked immunosorbent assay (Elisa) testing market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – End User Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Application – Market share 2022-2027 (%)
Exhibits31: Data Table on Application – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Vaccine development – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Vaccine development – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Vaccine development – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Vaccine development – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Immunology – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Immunology – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Immunology – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Immunology – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Diagnostics – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Diagnostics – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Diagnostics – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Diagnostics – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Drug monitoring and pharmaceutical industry – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Drug monitoring and pharmaceutical industry – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Drug monitoring and pharmaceutical industry – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Drug monitoring and pharmaceutical industry – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Application ($ million)
Exhibits55: Chart on End-user – Market share 2022-2027 (%)
Exhibits56: Data Table on End-user – Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by End-user
Exhibits58: Data Table on Comparison by End-user
Exhibits59: Chart on Hospitals and diagnostic centers – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Hospitals and diagnostic centers – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Hospitals and diagnostic centers – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Hospitals and diagnostic centers – Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Research laboratories – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Research laboratories – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Research laboratories – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Research laboratories – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits71: Market opportunity by End-user ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits109: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits110: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits111: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits112: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits113: Market opportunity By Geographical Landscape ($ million)
Exhibits114: Impact of drivers and challenges in 2022 and 2027
Exhibits115: Overview on Criticality of inputs and Factors of differentiation
Exhibits116: Overview on factors of disruption
Exhibits117: Impact of key risks on business
Exhibits118: Vendors covered
Exhibits119: Matrix on vendor position and classification
Exhibits120: Abbott Laboratories – Overview
Exhibits121: Abbott Laboratories – Business segments
Exhibits122: Abbott Laboratories – Key news
Exhibits123: Abbott Laboratories – Key offerings
Exhibits124: Abbott Laboratories – Segment focus
Exhibits125: Abcam plc – Overview
Exhibits126: Abcam plc – Product / Service
Exhibits127: Abcam plc – Key news
Exhibits128: Abcam plc – Key offerings
Exhibits129: Agilent Technologies Inc. – Overview
Exhibits130: Agilent Technologies Inc. – Business segments
Exhibits131: Agilent Technologies Inc. – Key news
Exhibits132: Agilent Technologies Inc. – Key offerings
Exhibits133: Agilent Technologies Inc. – Segment focus
Exhibits134: Avantor Inc. – Overview
Exhibits135: Avantor Inc. – Business segments
Exhibits136: Avantor Inc. – Key offerings
Exhibits137: Avantor Inc. – Segment focus
Exhibits138: Becton Dickinson and Co. – Overview
Exhibits139: Becton Dickinson and Co. – Business segments
Exhibits140: Becton Dickinson and Co. – Key news
Exhibits141: Becton Dickinson and Co. – Key offerings
Exhibits142: Becton Dickinson and Co. – Segment focus
Exhibits143: Bio Rad Laboratories Inc. – Overview
Exhibits144: Bio Rad Laboratories Inc. – Business segments
Exhibits145: Bio Rad Laboratories Inc. – Key news
Exhibits146: Bio Rad Laboratories Inc. – Key offerings
Exhibits147: Bio Rad Laboratories Inc. – Segment focus
Exhibits148: bioMerieux SA – Overview
Exhibits149: bioMerieux SA – Product / Service
Exhibits150: bioMerieux SA – Key offerings
Exhibits151: Danaher Corp. – Overview
Exhibits152: Danaher Corp. – Business segments
Exhibits153: Danaher Corp. – Key news
Exhibits154: Danaher Corp. – Key offerings
Exhibits155: Danaher Corp. – Segment focus
Exhibits156: Eppendorf SE – Overview
Exhibits157: Eppendorf SE – Product / Service
Exhibits158: Eppendorf SE – Key news
Exhibits159: Eppendorf SE – Key offerings
Exhibits160: Merck KGaA – Overview
Exhibits161: Merck KGaA – Business segments
Exhibits162: Merck KGaA – Key news
Exhibits163: Merck KGaA – Key offerings
Exhibits164: Merck KGaA – Segment focus
Exhibits165: Novo Nordisk AS – Overview
Exhibits166: Novo Nordisk AS – Business segments
Exhibits167: Novo Nordisk AS – Key offerings
Exhibits168: Novo Nordisk AS – Segment focus
Exhibits169: Perkin Elmer Inc – Overview
Exhibits170: Perkin Elmer Inc – Business segments
Exhibits171: Perkin Elmer Inc – Key news
Exhibits172: Perkin Elmer Inc – Key offerings
Exhibits173: Perkin Elmer Inc – Segment focus
Exhibits174: QIAGEN NV – Overview
Exhibits175: QIAGEN NV – Product / Service
Exhibits176: QIAGEN NV – Key news
Exhibits177: QIAGEN NV – Key offerings
Exhibits178: Siemens Healthineers AG – Overview
Exhibits179: Siemens Healthineers AG – Business segments
Exhibits180: Siemens Healthineers AG – Key news
Exhibits181: Siemens Healthineers AG – Key offerings
Exhibits182: Siemens Healthineers AG – Segment focus
Exhibits183: Thermo Fisher Scientific Inc. – Overview
Exhibits184: Thermo Fisher Scientific Inc. – Business segments
Exhibits185: Thermo Fisher Scientific Inc. – Key news
Exhibits186: Thermo Fisher Scientific Inc. – Key offerings
Exhibits187: Thermo Fisher Scientific Inc. – Segment focus
Exhibits188: Inclusions checklist
Exhibits189: Exclusions checklist
Exhibits190: Currency conversion rates for US$
Exhibits191: Research methodology
Exhibits192: Validation techniques employed for market sizing
Exhibits193: Information sources
Exhibits194: List of abbreviations
|

※본 조사보고서 [세계의 효소 면역 측정 (ELISA) 검사 시장 (2023~2027) : 백신 개발, 면역, 진단, 약물 모니터링 및 제약, 기타] (코드 : IRTNTR41149-23) 판매에 관한 면책사항을 반드시 확인하세요. |
※본 조사보고서 [세계의 효소 면역 측정 (ELISA) 검사 시장 (2023~2027) : 백신 개발, 면역, 진단, 약물 모니터링 및 제약, 기타] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!